Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain.

Burke JR, Cheng L, Gillooly KM, Strnad J, Zupa-Fernandez A, Catlett IM, Zhang Y, Heimrich EM, McIntyre KW, Cunningham MD, Carman JA, Zhou X, Banas D, Chaudhry C, Li S, D'Arienzo C, Chimalakonda A, Yang X, Xie JH, Pang J, Zhao Q, Rose SM, Huang J, Moslin RM, Wrobleski ST, Weinstein DS, Salter-Cid LM.

Sci Transl Med. 2019 Jul 24;11(502). pii: eaaw1736. doi: 10.1126/scitranslmed.aaw1736.

PMID:
31341059
2.

Neonatal postgraduate training program for physician assistants: meeting a need in neonatal care.

Abu Jawdeh EG, Hardin-Fanning F, Kinnard TB, Cunningham MD.

J Perinatol. 2019 May;39(5):746-753. doi: 10.1038/s41372-019-0350-9. Epub 2019 Mar 11.

PMID:
30858612
3.

Domestic Homicide: Neuropsychological Profiles of Murderers Who Kill Family Members and Intimate Partners.

Hanlon RE, Brook M, Demery JA, Cunningham MD.

J Forensic Sci. 2016 Jan;61 Suppl 1:S163-70. doi: 10.1111/1556-4029.12908. Epub 2015 Aug 21.

PMID:
26292990
4.

Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core.

Xiao HY, Wu DR, Sheppeck JE 2nd, Habte SF, Cunningham MD, Somerville JE, Barrish JC, Nadler SG, Dhar TG.

Bioorg Med Chem Lett. 2013 Oct 15;23(20):5571-4. doi: 10.1016/j.bmcl.2013.08.049. Epub 2013 Aug 16.

PMID:
24011644
5.

Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.

Sheppeck JE 2nd, Gilmore JL, Xiao HY, Dhar TG, Nirschl D, Doweyko AM, Sack JS, Corbett MJ, Malley MF, Gougoutas JZ, Mckay L, Cunningham MD, Habte SF, Dodd JH, Nadler SG, Somerville JE, Barrish JC.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5442-7. doi: 10.1016/j.bmcl.2013.06.089. Epub 2013 Jul 9.

PMID:
23953070
6.

Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.

Gilmore JL, Sheppeck JE 2nd, Wang J, Dhar TG, Cavallaro C, Doweyko AM, Mckay L, Cunningham MD, Habte SF, Nadler SG, Dodd JH, Somerville JE, Barrish JC.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5448-51. doi: 10.1016/j.bmcl.2013.06.085. Epub 2013 Jul 4.

PMID:
23916594
7.

Probability of criminal acts of violence: a test of jury predictive accuracy.

Reidy TJ, Sorensen JR, Cunningham MD.

Behav Sci Law. 2013 Mar-Apr;31(2):286-305. doi: 10.1002/bsl.2064. Epub 2013 Apr 24.

PMID:
23613146
8.

Wapl antagonizes cohesin binding and promotes Polycomb-group silencing in Drosophila.

Cunningham MD, Gause M, Cheng Y, Noyes A, Dorsett D, Kennison JA, Kassis JA.

Development. 2012 Nov;139(22):4172-9. doi: 10.1242/dev.084566. Epub 2012 Oct 3.

9.

Community violence to prison assault: a test of the behavioral continuity hypothesis.

Reidy TJ, Sorensen JR, Cunningham MD.

Law Hum Behav. 2012 Aug;36(4):356-63. doi: 10.1037/h0093934.

PMID:
22849420
10.

Life and death in the Lone Star State: three decades of violence predictions by capital juries.

Cunningham MD, Sorensen JR, Vigen MP, Woods SO.

Behav Sci Law. 2011 Jan-Feb;29(1):1-22. doi: 10.1002/bsl.963. Epub 2010 Nov 23.

PMID:
21105010
11.

Improbable predictions at capital sentencing: contrasting prison violence outcomes.

Cunningham MD, Sorensen JR.

J Am Acad Psychiatry Law. 2010;38(1):61-72.

PMID:
20305077
12.

Chromatin modifiers, cognitive disorders, and imprinted genes.

Cunningham MD, Kassis JA, Pfeifer K.

Dev Cell. 2010 Feb 16;18(2):169-70. doi: 10.1016/j.devcel.2010.01.012.

13.

Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators.

Xiao HY, Wu DR, Malley MF, Gougoutas JZ, Habte SF, Cunningham MD, Somerville JE, Dodd JH, Barrish JC, Nadler SG, Dhar TG.

J Med Chem. 2010 Feb 11;53(3):1270-80. doi: 10.1021/jm901551w.

PMID:
20047280
14.

Characterization of the polycomb group response elements of the Drosophila melanogaster invected Locus.

Cunningham MD, Brown JL, Kassis JA.

Mol Cell Biol. 2010 Feb;30(3):820-8. doi: 10.1128/MCB.01287-09. Epub 2009 Nov 30.

15.

Assertions of "future dangerousness" at federal capital sentencing: rates and correlates of subsequent prison misconduct and violence.

Cunningham MD, Reidy TJ, Sorensen JR.

Law Hum Behav. 2008 Feb;32(1):46-63. Epub 2007 Sep 18.

PMID:
17876695
16.

Neonatal latex allergy.

Cunningham MD.

J Perinatol. 2007 Sep;27(9):533-4. No abstract available.

PMID:
17724453
17.

Capital offenders in Texas prisons: rates, correlates, and an actuarial analysis of violent misconduct.

Cunningham MD, Sorensen JR.

Law Hum Behav. 2007 Dec;31(6):553-71. Epub 2007 Mar 23.

PMID:
17380371
18.

Dangerousness and death: a nexus in search of science and reason.

Cunningham MD.

Am Psychol. 2006 Nov;61(8):828-839. doi: 10.1037/0003-066X.61.8.828.

PMID:
17115827
19.
20.

Is death row obsolete? A decade of mainstreaming death-sentenced inmates in Missouri.

Cunningham MD, Reidy TJ, Sorensen JR.

Behav Sci Law. 2005;23(3):307-20.

PMID:
15968709
21.

An actuarial model for assessment of prison violence risk among maximum security inmates.

Cunningham MD, Sorensen JR, Reidy TJ.

Assessment. 2005 Mar;12(1):40-9.

PMID:
15695742
22.

An intracellular targeted NLS peptide inhibitor of karyopherin alpha:NF-kappa B interactions.

Cunningham MD, Cleaveland J, Nadler SG.

Biochem Biophys Res Commun. 2003 Jan 10;300(2):403-7.

PMID:
12504098
23.

Death row inmate characteristics, adjustment, and confinement: a critical review of the literature.

Cunningham MD, Vigen MP.

Behav Sci Law. 2002;20(1-2):191-210. Review.

PMID:
11979498
24.
25.

CD14 employs hydrophilic regions to "capture" lipopolysaccharides.

Cunningham MD, Shapiro RA, Seachord C, Ratcliffe K, Cassiano L, Darveau RP.

J Immunol. 2000 Mar 15;164(6):3255-63.

26.

High-throughput functional detection of NMDA receptor activity.

Cunningham MD, Cunningham SM.

Methods Mol Biol. 1999;128:179-88. Review. No abstract available.

PMID:
10320983
27.

Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: implications for myeloid and nonmyeloid cell activation.

Cunningham MD, Bajorath J, Somerville JE, Darveau RP.

Clin Infect Dis. 1999 Mar;28(3):497-504.

PMID:
10194067
28.
29.

Integrating base rate data in violence risk assessments at capital sentencing.

Cunningham MD, Reidy TJ.

Behav Sci Law. 1998 Winter;16(1):71-95. Review.

PMID:
9549880
30.
31.
32.

Identification of CD14 residues involved in specific lipopolysaccharide recognition.

Shapiro RA, Cunningham MD, Ratcliffe K, Seachord C, Blake J, Bajorath J, Aruffo A, Darveau RP.

Infect Immun. 1997 Jan;65(1):293-7.

33.

Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14.

Cunningham MD, Seachord C, Ratcliffe K, Bainbridge B, Aruffo A, Darveau RP.

Infect Immun. 1996 Sep;64(9):3601-8.

34.
35.

Failure of a hydroxyapatite-coated endosteal dental implant: a clinical report.

Taylor JC, Driscoll CF, Cunningham MD.

J Prosthet Dent. 1996 Apr;75(4):353-5. No abstract available.

PMID:
8642517
36.

A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

Somerville JE Jr, Cassiano L, Bainbridge B, Cunningham MD, Darveau RP.

J Clin Invest. 1996 Jan 15;97(2):359-65.

37.

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.

Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS.

Am J Respir Crit Care Med. 1996 Jan;153(1):404-10.

PMID:
8542150
38.

Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion.

Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, Dietsch M, Page RC, Aruffo A.

Infect Immun. 1995 Apr;63(4):1311-7.

39.

The ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and neutrophil adhesion.

Darveau RP, Cunningham MD, Seachord CL, Page RC, Aruffo A.

Prog Clin Biol Res. 1995;392:69-78. No abstract available.

PMID:
8524966
40.

Focal intestinal perforation in the extremely-low-birth-weight infant.

Novack CM, Waffarn F, Sills JH, Pousti TJ, Warden MJ, Cunningham MD.

J Perinatol. 1994 Nov-Dec;14(6):450-3.

PMID:
7876936
41.

Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention.

Cunningham MD, Ferkany JW, Enna SJ.

Life Sci. 1994;54(3):135-48. Review.

PMID:
8289575
42.

Hemorrhagic adrenal cyst.

Cunningham MD.

J Am Osteopath Assoc. 1993 May;93(5):619-22.

PMID:
8314725
43.

Adherence of Candida albicans to immobilized extracellular matrix proteins is mediated by calcium-dependent surface glycoproteins.

Klotz SA, Rutten MJ, Smith RL, Babcock SR, Cunningham MD.

Microb Pathog. 1993 Feb;14(2):133-47.

PMID:
8502162
44.

Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.

Darveau RP, Blake J, Seachord CL, Cosand WL, Cunningham MD, Cassiano-Clough L, Maloney G.

J Clin Invest. 1992 Aug;90(2):447-55.

45.

Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo.

Darveau RP, Cunningham MD, Seachord CL, Cassiano-Clough L, Cosand WL, Blake J, Watkins CS.

Antimicrob Agents Chemother. 1991 Jun;35(6):1153-9.

46.
48.

Reintroduction of continuous negative pressure ventilation in neonates: two-year experience.

Cvetnic WG, Cunningham MD, Sills JH, Gluck L.

Pediatr Pulmonol. 1990;8(4):245-53.

PMID:
2196512
49.
50.

Clinical evaluation of a direct fluorescent monoclonal antibody test for detection of Pseudomonas aeruginosa in blood cultures.

Pfaller MA, Barrett M, Koontz FP, Wenzel RP, Cunningham MD, Rollins N, Darveau RP.

J Clin Microbiol. 1989 Mar;27(3):558-60.

Supplemental Content

Loading ...
Support Center